Archived Webcast

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

Release Date

December 10, 2022

Expiration Date

February 2, 2023

Credits

3.0 CME

Release Date: December 10, 2022

Expiration Date: February 1, 2023

Activity Overview

This educational activity is an archive of the live virtual presentation held on December 9, 2022.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This activity is intended for medical oncologists, hematologists, and other oncology healthcare professionals interested in the latest advances in MRD monitoring for patients with hematologic malignancies. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in MRD monitoring for patients with hematologic malignancies are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain best practices in the assessment of MRD across hematologic malignancies, including the techniques and platforms
  • Determine guideline recommendations and expert consensus to inform the use of MRD monitoring in hematologic malignancies’ settings
  • Analyze the role of MRD assessment when planning treatment across the continuum of care for hematologic malignancies
  • Formulate plans to integrate emerging data, sampling techniques, MRD assessment, and clinical trial data into the management of patients with hematologic malignancies.
MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Educational Grant Support

This activity is supported by educational grants from AbbVie, Inc; Janssen Biotech, Inc, administered by Janssen Scientific Affairs, LLC; Sanofi Genzyme.

Course

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

Create Account